ANIX NASDAQ
Anixa Biosciences, Inc.
1W: -9.5%
1M: -14.6%
3M: +11.3%
YTD: -12.7%
1Y: -8.6%
3Y: -21.8%
5Y: -49.6%
$2.76
+0.01 (+0.36%)
Weekly Expected Move ±8.7%
$2
$3
$3
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Last Earnings
2026-09-09
EPS
$-0.08
▲ Beat +2.2%
Revenue
—
EPS Beat Streak: 3 quarters
Next Earnings
Qtr ending 2026-10-30 · date TBD
EPS Estimate
$-0.08
Range: $-0.08 - $-0.08
Estimate vs Actual
Earnings Surprise History
14/20
EPS Beats
0/20
Revenue Beats
70%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-09-10 | quarter | 2028-07-31 | $-0.07 | $-0.09 | ▼ 0.02 | $— | $— |
| 2026-09-10 | quarter | 2027-01-31 | $-0.09 | $-0.08 | — | $— | $— |
| 2026-09-10 | quarter | 2027-10-31 | $-0.10 | $-0.08 | ▲ 0.02 | $— | $— |
| 2026-09-10 | quarter | 2026-10-31 | $-0.09 | $-0.08 | ▲ 0.01 | $— | $— |
| 2026-09-10 | quarter | 2027-07-31 | $-0.10 | $-0.08 | ▲ 0.02 | $— | $— |
| 2026-09-10 | quarter | 2028-10-31 | $-0.07 | $-0.10 | ▼ 0.03 | $— | $— |
| 2026-09-10 | quarter | 2028-01-31 | $-0.06 | $-0.08 | ▼ 0.02 | $— | $— |
| 2026-09-10 | quarter | 2026-07-31 | $-0.09 | $-0.08 | — | $— | $— |
| 2026-08-11 | quarter | 2019-07-31 | $— | $-0.11 | ▼ 0.11 | $— | $442,307 |
| 2026-08-11 | annual | 2016-10-31 | $— | $2.25 | ▲ 2.25 | $— | $45,000,000 |
| 2026-08-11 | annual | 2021-10-31 | $— | $-0.41 | ▼ 0.41 | $— | $500,000 |
| 2026-08-11 | annual | 2017-10-31 | $— | $3.50 | ▲ 3.50 | $— | $60,000,000 |
| 2026-08-11 | quarter | 2021-04-30 | $— | $-0.10 | ▼ 0.10 | $— | $605,681 |
| 2026-08-11 | annual | 2015-10-31 | $— | $2.25 | ▲ 2.25 | $— | $45,000,000 |
| 2026-08-11 | annual | 2019-10-31 | $— | $-0.71 | ▼ 0.71 | $— | $250,000 |
Earnings Call Transcripts
No transcripts available.